STAGE IV UTERINE CORPUS CANCER AJCC V7
Clinical trials for STAGE IV UTERINE CORPUS CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV UTERINE CORPUS CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV UTERINE CORPUS CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer-Fighting virus trial seeks to target tumors
Disease control OngoingThis early-stage trial is testing a modified virus designed to infect and kill cancer cells in patients with advanced or recurrent endometrial cancer. The main goal is to find a safe dose and understand the side effects. Some patients also receive an additional oral drug that may…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V7
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 04, 2026 08:21 UTC
-
Hot chemo bath during surgery tested for Tough-to-Treat cancers
Disease control OngoingThis early-stage study is testing whether washing the abdomen with heated chemotherapy during cancer-removal surgery is safe and feasible for patients with advanced or recurrent ovarian, fallopian tube, uterine, or peritoneal cancers. The goal is to see if this approach, sometime…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists test new pill cocktails in fight against tough cancers
Disease control OngoingThis early-stage trial is testing the safety and best doses of two different combinations of oral medications for people with recurrent endometrial, ovarian, or triple-negative breast cancer. The study combines an existing drug (olaparib) with one of two newer drugs (AZD2014 or A…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC